CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,966,069
- in 2 filings, $18.0M under 10b5-1 plans
Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −2,039 | $310.94 | $634K | 1,378,395 |
| 2026-06-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −240 | $311.65 | $75K | 1,378,155 |
| 2026-06-04 | Krishnan Krish S President and CEO | Sale 10b5-1 | −320 | $300.75 | $96K | 1,474,933 |
| 2026-06-04 | Krishnan Krish S President and CEO | Sale 10b5-1 | −640 | $302.24 | $193K | 1,474,293 |
| 2026-06-04 | Krishnan Krish S President and CEO | Sale 10b5-1 | −176 | $303.17 | $53K | 1,474,117 |
| 2026-06-04 | Krishnan Krish S President and CEO | Sale 10b5-1 | −544 | $304.81 | $166K | 1,473,573 |
| 2026-06-04 | Krishnan Krish S President and CEO | Sale 10b5-1 | −589 | $306.33 | $180K | 1,472,984 |
| 2026-06-04 | Krishnan Krish S President and CEO | Sale 10b5-1 | −11,461 | $307.68 | $3.5M | 1,461,523 |
| 2026-06-04 | Krishnan Krish S President and CEO | Sale 10b5-1 | −4,830 | $308.47 | $1.5M | 1,456,693 |
| 2026-06-04 | Krishnan Krish S President and CEO | Sale 10b5-1 | −2,784 | $309.49 | $862K | 1,453,909 |
| 2026-06-04 | Krishnan Krish S President and CEO | Sale 10b5-1 | −2,652 | $310.43 | $823K | 1,451,257 |
| 2026-06-04 | Krishnan Krish S President and CEO | Sale 10b5-1 | −964 | $311.36 | $300K | 1,450,293 |
| 2026-06-04 | Krishnan Krish S President and CEO | Sale 10b5-1 | −40 | $312.23 | $12K | 1,450,253 |
| 2026-05-26 | Thomas John Charles EVP, General Counsel | Sale 10b5-1 | −642 | $302.03 | $194K | 0 |
| 2026-03-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −407 | $257.32 | $105K | 1,427,748 |
| 2026-03-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −589 | $258.54 | $152K | 1,427,159 |
| 2026-03-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −668 | $259.61 | $173K | 1,426,491 |
| 2026-03-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −3,667 | $260.37 | $955K | 1,422,824 |
| 2026-03-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −2,931 | $261.41 | $766K | 1,419,893 |
| 2026-03-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −1,938 | $262.35 | $508K | 1,417,955 |
Page 4 of 35 · 689 trades